Recalls
When a product is unsafe or breaks the rules, the company pulls it back and FDA classes the recall. Class I could cause serious harm or death. Class II could cause temporary harm. Class III is unlikely to hurt anyone.
5,413 recalls in the last 12 months. Newest first.
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0684-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Outlook set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with corresponding… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0709-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0700-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Extension Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with correspondi… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0637-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0688-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Extension Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with correspondi… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0633-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0686-2026 |
| Dec 3, 2025 | Class II | Cepheid Device |
Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10. Product testing did not meet expected stability criteria. FDA notice Z-0724-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0651-2026 |
| Dec 3, 2025 | Class II | Foundation Medicine, Inc. Device |
FoundationOne CDx (F1CDx), RAL-0003 version 31.0 Reports were sent to customers without the companion diagnostic (CDx) Claims Page. Claims pages were distributed via amended reports within 7 days of the issue occurrence. FDA notice Z-0577-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0675-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0705-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0679-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Extension Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with correspondi… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0639-2026 |
| Dec 3, 2025 | Class II | Noah Medical Corporation Device |
Brand Name: Galaxy System Product Name: Galaxy System Model/Catalog Number: GAL-001 Product Description: The Galaxy SystemTM and its accessories are intended to provide bronchoscopic visualization of and access to pa… Due to Users not having access to the Instructions for Use/User Manual due to it being password protected. FDA notice Z-0598-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Infusomat utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with corresponding c… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0640-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Anesthesia IV Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with corresp… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0607-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0647-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
SafeDAY set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with corresponding… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0712-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Blood Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with … Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0616-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0656-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Blood Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with … Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0617-2026 |
| Nov 26, 2025 | Class I | Twin Sisters Creamery, LLC Food |
Twin Sisters Creamery Peppercorn cheese, 3lb. round cheese wheel, made with raw milk and aged at minimum of 60 days. Ingredients: cultured raw cow's milk, whole peppercorns, salt, enzymes. Made in Ferndale, WA. www.twins… Raw milk Peppercorn cheese is recalled due to E.coli O26:H11 FDA notice H-0195-2026 |
| Nov 26, 2025 | Class I | Peterson Company Inc Food |
Item# 28855 Whatcom Blue, Twin Sisters Creamery brand, product is packed in Cryovac and each package weighs 5oz-6oz. There are 16 pieces per case. This cheese is made from raw milk. Ingredients: cultured raw cow's milk,… Item #28855 Whatcom Blue is recalled due to E. coli O103:H2 FDA notice H-0197-2026 |
| Nov 26, 2025 | Class I | Plenus Group Inc. Food |
Rockport Lobser Bisque; packed in 2x8lb pouches and in 4x4b pouches Products contain undeclared shrimp (crustacean shellfish) FDA notice H-0201-2026 |
| Nov 26, 2025 | Class II | Haitai, Inc. Food |
Cinnamon Powder; 8oz clear plastic container. Distributed by Haitai Inc. UPC: 0 20914 81415 9 Elevated levels of lead in Cinnamon powder. FDA notice H-0203-2026 |
| Nov 26, 2025 | Class I | Twin Sisters Creamery, LLC Food |
Twin Sisters Creamery Farmhouse Cheese, 3lb. round cheese wheel, made with raw milk and aged at minimum of 60 days. Ingredients: cultured raw cow's milk, salt, and enzymes. Made in Ferndale, WA. www.twinsisterscreamery.c… Raw milk Farmhouse cheeses are recalled due to E. coli O103:H2 and E. coli O74:H25. FDA notice H-0194-2026 |
| Nov 26, 2025 | Class I | Twin Sisters Creamery, LLC Food |
Twin Sisters Creamery Mustard Seed cheese, 3lb. round cheese wheel, made with raw milk and aged at minimum of 60 days. Ingredients: Cultured raw cow's milk, salt, whole yellow mustard seeds and enzymes. Made in Ferndale,… Raw milk Mustard Seed cheese is recalled due to E. coli O103:H2 and E. coli O74:H25. FDA notice H-0196-2026 |
| Nov 26, 2025 | Class I | Publix Super Markets, Inc. Food |
Publix Rich & Creamy Vanilla Ice Cream Undeclared Eggs FDA notice H-0192-2026 |
| Nov 26, 2025 | Class I | BULK & ORGANIC LLC Food |
Bulk and Organic Organic Moringa Powder, 44.1lbs bag Possible Salmonella Richmond FDA notice H-0204-2026 |
| Nov 26, 2025 | Class I | New Hoque and Sons, Inc. Food |
Dry Ghoinnya Fish Un-eviscerated fish may be contaminated with Clostridia botulinum. FDA notice H-0202-2026 |
| Nov 26, 2025 | Class I | Peterson Company Inc Food |
Item# 29608 Farmhouse White, Twin Sisters Creamery brand, product is packed in Cryovac and each package weighs 5oz-6oz. This cheese is made from raw milk. Ingredients: cultured raw cow's milk, salt, enzymes, penicillium… Item #29608 Farmhouse White is recalled due to E. coli O103:H2. FDA notice H-0198-2026 |
| Nov 26, 2025 | Class I | Twin Sisters Creamery, LLC Food |
Twin Sisters Creamery Whatcom Blue cheese, 2.5lb. round cheese wheel, made with raw milk and aged at minimum of 60 days. Ingredients: cultured raw cow's milk, salt, enzymes, penicillium roqueforti. Made in Ferndale, WA. … Raw milk Whatcom Blue cheese is recalled due to E. coli O103:H2. FDA notice H-0193-2026 |
| Nov 26, 2025 | Class II | DermaRite Industries, LLC Drug |
DermaCerin, Skin Protectant Moisturizing Cream (petrolatum 33%), packaged in a) 106 g (3.75 oz.) per tube (NDC 61924-174-04) and b) 454 g (16 oz.) per jar (NDC 61924-174-16), DermaRite Industries LLC, 7777 West Side Aven… CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated. FDA notice D-0161-2026 |
| Nov 26, 2025 | Class III | Alembic Pharmaceuticals Limited Drug |
Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminst… Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit. FDA notice D-0156-2026 |
| Nov 26, 2025 | Class II | DermaRite Industries, LLC Drug |
4-N-1 Skin Protectant, No Rinse Wash Cream with Dimethicone 1%, 113g, (4 oz) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-208-04 CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated. FDA notice D-0160-2026 |
| Nov 26, 2025 | Class III | Imprimis NJOF, LLC Drug |
Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office Use Only, 5.5 mL bottle, Rx only, Mfg by: Imprimis NJOF, LLC, 1705 Route 46 West, Ledgewood, NJ 07852,… Subpotent Drug FDA notice D-0157-2026 |
| Nov 26, 2025 | Class II | DermaRite Industries, LLC Drug |
McKesson Skin Protectant, Lanolin USP, packaged in a) 5g (NDC 68599-6202-1), and b) 4oz NDC 68599-6203-4 tube, Distributed by McKesson Medical-Surgical Inc., Richmond, VA 23233. CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated. FDA notice D-0171-2026 |
| Nov 26, 2025 | Class II | Zydus Pharmaceuticals (USA) Inc Drug |
Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle, Rx Only. Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals, Pennington, NJ 08534. NDC 68382-110-06 Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules. FDA notice D-0159-2026 |
| Nov 26, 2025 | Class II | DermaRite Industries, LLC Drug |
Lantiseptic, Dry Skin Therapy, Lanolin USP 30%, packaged in a) 5 g (0.17 oz) (NDC 61924-504-05), b) 4 oz (NDC 61924-504-04), and c)14 oz (NDC 61924-710-14) tubes, DermaRite Industries LLC, 7777 West Side Avenue, North Be… CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated. FDA notice D-0169-2026 |
| Nov 26, 2025 | Class II | DermaRite Industries, LLC Drug |
Renew Skin Repair Cream, Dimethicone 1.5%, packaged in a) 5g tube (NDC 61924-405-05), b) 4 oz tube (NDC 61924-405-04), and c) 800 mL (NDC 61924-405-27), DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 0… CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated. FDA notice D-0175-2026 |
| Nov 26, 2025 | Class II | Park Avenue Compounding Drug |
Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1. CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results. FDA notice D-0178-2026 |
| Nov 26, 2025 | Class I | Otsuka ICU Medical LLC Drug |
POTASSIUM CHLORIDE Inj., 20 mEq total in 50 mL Flexible Container, Highly concentrated 400 mEq/L, Rx Only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC# 0990-7077-14 Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq FDA notice D-0180-2026 |
| Nov 26, 2025 | Class II | DermaRite Industries, LLC Drug |
Hand-E-Foam, Benzethonium Chloride 0.20%, packaged in a) 236mL (NDC 61924-102-08) and b) 1000 mL (NDC 61924-102-34) per container, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated. FDA notice D-0167-2026 |
| Nov 26, 2025 | Class II | DermaRite Industries, LLC Drug |
GelRite Instant Hand Sanitizer, Alcohol 65%, packaged in a) 118 mL (NDC 61924-106-04), b) 473 mL (NDC 61924-106-16) and c) 800 mL (NDC 61924-106-27), and d) 1000 mL (NDC 61924-106-34) per container, DermaRite Industries … CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated. FDA notice D-0166-2026 |
| Nov 26, 2025 | Class II | DermaRite Industries, LLC Drug |
UltraSure Anti-Perspirant & Deodorant, Aluminum Sesquichlorohydrate 15%, 118 mL (4 fl. oz.), DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-266-04 CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated. FDA notice D-0177-2026 |
| Nov 26, 2025 | Class I | Otsuka ICU Medical LLC Drug |
POTASSIUM CHLORIDE Inj., 10 mEq total in 100 mL Flexible Container, Highly concentrated 100 mEq/L, Rx Only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC# 0990-7074-26 Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq FDA notice D-0181-2026 |
| Nov 26, 2025 | Class II | DermaRite Industries, LLC Drug |
San-E-Foam, Alcohol 67%, 1000 mL (34 fl. oz.) per cartridge, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-107-34 CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated. FDA notice D-0176-2026 |
| Nov 26, 2025 | Class II | DermaRite Industries, LLC Drug |
DermaKleen, Health Care Antiseptic Lotion Soap with Vitamin E, Chloroxylenol 0.2%, packaged in a) 222 mL (7.5 fl. oz.) per tube (NDC 61924-092-08), b) 800 mL (27 fl. oz.) per bag (NDC 61924-092-27), and c 1000 mL (34 fl.… CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated. FDA notice D-0163-2026 |
| Nov 26, 2025 | Class II | Golden State Medical Supply Inc. Drug |
NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals, Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274. Packaged by GSMS, Incorpora… Failed Dissolution Specifications FDA notice D-0158-2026 |